Agile Therapeutics
AGRX
#10907
Rank
NZ$19.05 M
Marketcap
NZ$2.76
Share price
0.00%
Change (1 day)
328.75%
Change (1 year)

Earnings for Agile Therapeutics (AGRX)

Earnings in 2024 (TTM): -NZ$24.37 Million

According to Agile Therapeutics 's latest financial reports the company's current earnings are NZ$21.56 Million. In 2023 the company made an earning of -NZ$23.86 Million a decrease over its 2022 earnings that were of -NZ$8.76 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agile Therapeutics from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$24.37 Million2.14%
2023 -NZ$23.86 Million172.57%
2022 -NZ$8.76 Million-93.26%
2021 -NZ$0.13 Billion45.62%
2020 -NZ$89.11 Million161.98%
2019 -NZ$34.02 Million-2.78%
2018 -NZ$34.99 Million-27.47%
2017 -NZ$48.24 Million-10.16%
2016 -NZ$53.69 Million-14.2%
2015 -NZ$62.58 Million88.45%
2014 -NZ$33.21 Million41.72%
2013 -NZ$23.43 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$34.22 B-124,690.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$12.73 B-46,472.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.28 B-44,842.45%๐Ÿ‡บ๐Ÿ‡ธ USA
TherapeuticsMD
TXMD
NZ$0.21 M-100.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Antares Pharma
ATRS
NZ$0.12 B-538.45%๐Ÿ‡บ๐Ÿ‡ธ USA